335605 <common-name>5-[3-[(2s)-1-(difluoromethoxy)propan-2-yl]oxy-5-[(5-methylpyrazin-2-yl)carbamoyl]phenoxy]-n,n-dimethylpyrazine-2-carboxamide</common-name> <description>5-[3-[(2s)-1-(difluoromethoxy)propan-2-yl]oxy-5-[(5-methylpyrazin-2-yl)carbamoyl]phenoxy]-n,n-dimethylpyrazine-2-carboxamide is a chemical compound with the formula C23H24F2N6O5. With an average molecular weight of 502.50 g/mol, 5-[3-[(2s)-1-(difluoromethoxy)propan-2-yl]oxy-5-[(5-methylpyrazin-2-yl)carbamoyl]phenoxy]-n,n-dimethylpyrazine-2-carboxamide is a heavy molecule.</description> <cas>1020668-59-0</cas> <pubchem-id>25096253</pubchem-id> <chemical-formula>C23H24F2N6O5</chemical-formula> <weight>502.5</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-30T17:48:37Z</created-at> <updated-at type="dateTime">2026-08-30T17:48:37Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC1=CN=C(C=N1)NC(=O)C2=CC(=CC(=C2)OC(C)COC(F)F)OC3=NC=C(N=C3)C(=O)N(C)C</moldb-smiles> <moldb-formula>C23H24F2N6O5</moldb-formula> <moldb-inchi>InChI=1S/C23H24F2N6O5/c1-13-8-28-19(10-26-13)30-21(32)15-5-16(35-14(2)12-34-23(24)25)7-17(6-15)36-20-11-27-18(9-29-20)22(33)31(3)4/h5-11,14,23H,12H2,1-4H3,(H,28,30,32)/t14-/m0/s1</moldb-inchi> <moldb-inchikey>RBYJCAVKEDZBDN-AWEZNQCLSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">502.1776242</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>2.1</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM331498</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>5-[3-[(2s)-1-(difluoromethoxy)propan-2-yl]oxy-5-[(5-methylpyrazin-2-yl)carbamoyl]phenoxy]-n,n-dimethylpyrazine-2-carboxamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organic oxygen compounds</superklass> <klass>Organooxygen compounds</klass> <subklass>Ethers</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0286075</sync-id> <structure-inchikey>RBYJCAVKEDZBDN-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>400000801000404000008000000002000000000000000000000000000000000000000010000001082000000000000020000000200000000000000000020000000000000000000000000100000000000000200080000041000000100000000000080000000100000000000100001040000000000200000000000002000000000003000020cc02000000100000000000008050000000000000040000000000002000000000000000000202000008c000000000000000080000000000000000000100000010200000040000400000000400000000000000002210000000000000001000008000000000040040000100000400800000000000000000000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAkAAAAJgAAAIABBgBgAAAAAQMGQCgAAAAD BAZAaAAAAAMDAQdAKAAAAAMDBkAoAAAAAwQGQGgAAAADAwEHQCgAAAADAwcA aAAAAAMCAQYAKAAAAAMECAAoAAAAAwIGQCgAAAADBAZAaAAAAAMDAQZAKAAA AAMEBkBoAAAAAwMBBkAoAAAAAwQGQGgAAAADAwEIACgAAAADAgYAYAAAAAMB BgBgAAAAAQMGAGAAAAACAggAIAAAAAIGAGAAAAADAQkAIAAAAAEJACAAAAAB CAAoAAAAAwIGQCgAAAADBAdAKAAAAAMDBkBoAAAAAwMBBkAoAAAAAwQHQCgA AAADAwZAaAAAAAMDAQYAKAAAAAMECAAoAAAAAwIHACgAAAADAwYAYAAAAAED BgBgAAAAAQMLAAEAAQJoDAIDaAwDBGgMBAVoDAUGaAwEByAHCCAICSgCCAog CgtoDAsMaAwMDWgMDQ5oDA4PaAwOECAQEQAREgAREwATFAAUFQAVFgAVFwAM GCAYGSAZGmgMGhtoDBscaAwcHWgMHR5oDBwfIB8gKAIfISAhIgAhIwAGAWgM DwpoDB4ZaAxCAwAAAAYBBgUEAwIGCwwNDg8KBhobHB0eGRcEAAAAAAAAABY= </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:37:17Z</structure-indexed-at> </compound>